Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

World Congress of Bronchology and Interventional Pulmonology 2026

tuned for more details on the program, keynote speakers, and registration opening. Mark in your calendar and get ready to join experts, innovators, and thought leaders in Interventional Pulmonology from around the world.

3rd Global Summit on Heart and Cardiovascular Care 2026

taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the globe. 3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress...

VietPharma&Tech 2026

Vietnam Medical Devices Association highly appreciates Vietnam Advertisement and Fair Exhibition Joint Stock Company (VIETFAIR) organizing The international exhibition on Pharmaceutical Manufacturing Technology - VietPharmaTech 2026 / The...

Bruker Announces the Appointment of Institute Director, Biopharma Entrepreneur, and Immunology Leader Dr. Eicke Latz to Its Board of Directors

on venture formation and scaling, to senior advisory roles with major pharmaceutical companies. “It’s a great honor to join the Board of Directors at Bruker Corporation, a company at the forefront of AI-accelerated, deep functional proteomics,...

Bayer’s SUNHARBO® (asundexian) Receives FDA Approval for Stroke Risk Reduction

Investigator of the OCEANIC-STROKE clinical study and Senior Scientist at Population Health Research Institute (PHRI), a joint institute of Hamilton Health Sciences and McMaster University (Ontario, Canada). “I believe SUNHARBO introduces an...

BE BOLD: BIMZELX® (bimekizumab-bkzx) demonstrates superior joint response rates versus SKYRIZI® (risankizumab-rzaa) at Week 16, with sustained clinical improvements through Week 24

on the study's previously reported Week 16 results, which demonstrated statistically significant superiority in ACR50 joint outcomes versus risankizumab at Week 16 in psoriatic arthritis (PsA). Numerically greater rates of ACR50 were sustained...

Johnson & Johnson announces that ICOTYDE® (icotrokinra), a once-daily targeted oral peptide, delivers significant improvements in psoriatic arthritis disease activity among biologic-naïve patients

(ACR) Convergence 2026. Psoriatic arthritis is a chronic, immune-mediated inflammatory disease that can affect both the joints and skin.3,4 Nearly 30 percent of people with plaque psoriasis also develop psoriatic arthritis.5,6 It can cause pain,...

Stevanato Group and Aptar Pharma Collaborate to Accelerate Pre-Filled Syringe System Selection

Stevanato Group’s expertise in prefillable high-value syringe systems, primary containment and system performance. The joint work evaluates Stevanato Group’s EZ-fill® Nexa® and Alba® glass syringe platforms together with Aptar Pharma PremiumCoat®...

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

Generating antibodies that activate these receptors has been a longstanding goal in antibody discovery. Pythia-1 reasons jointly over amino acid sequence, three-dimensional atomic structure and explicit design specifications. The platform provides...

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

Generating antibodies that activate these receptors has been a longstanding goal in antibody discovery. Pythia-1 reasons jointly over amino acid sequence, three-dimensional atomic structure and explicit design specifications. The platform provides...

Aptar Pharma Expands Next-Generation Pulmonary Drug Delivery Capabilities with Acquisition of Pulmotree

stated, “The partnership between PULMOTREE and Aptar Pharma has been built on close, trust-based collaboration, and joining Aptar is the natural next step on that shared path. For our customers and partners, this acquisition is intended to provide...

Aptar Appoints Pharma Packaging Veteran Virginie Maes as President of its Pharma Business

dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma, effective January 1, 2027. Maes joins Aptar from Amcor, where she currently leads its global Flexibles Pharma and Medical packaging business, spanning North...

Hovione to Bring Next-Generation Continuous Tableting to the U.S. with the World’s First ConsiGma® CDC Flex Commissioning

under the international guidance have been approved by the U.S. Food and Drug Administration (FDA) alone. Developed jointly with GEA, the ConsiGma® CDC Flex platform also incorporates SimpleCT, a suite of automation and control tools with smart...

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies

CaseBioscience® announced its participation in a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its BioStabilization Systems (BoSS) program. Led...

Cresilon launched next-generation TRAUMAGEL.

application, go-bag optimization and a smaller footprint for tactical, prehospital and hospital use. The new form factor joins the original TRAUMAGEL, which will remain fully available and supported in the field. TRAUMAGEL is a plant-based...

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

TCR-based cancer immunotherapies, today announced the appointment of Peter Olagunju as Chief Executive Officer. Olagunju joins ImmunoScape as the company prepares to advance its Seed and Boost platform into the clinic. Co-founder Michael Fehlings,...

Scitara Appoints Mike Tarselli as Chief Strategy Officer to Drive Growth in Lab Intelligence

initiatives within their organizations. Mike will play a leading role in helping us make that transition.” “I’m excited to join the company to help power this scientific and strategic pivot. Late-stage labs are becoming increasingly automated:...

Abbott Launched the First and Only Ready-to-Feed Liquid Infant Formula Made with Whole Milk in the U.S. at a Price Similar to Its Existing Similac Powdered Formula

to the convenience of ready-to-feed formula at pricing similar to powder. Similac 360 Total Care Made With Whole Milk joins Abbott's extensive portfolio of infant formulas and expands feeding options for families seeking a formula made with whole...

Former DePuy Synthes U.S. President Joins Peptilogics Board

and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device businesses, including successful...

Bruker and Atinary Technologies Join Forces to Accelerate the Future of Self-Driving Laboratories

to train better models, increase success rates, and accelerate discovery. Atinary and Chemspeed have established a joint demonstration laboratory at Chemspeed’s headquarters near Basel, Switzerland. Atinary’s Self-Driving Lab in Boston opened in...

Results 1 - 20 of 145